US 12,263,009 B1
Movement disorder continuous monitoring and therapy system
Joseph P. Giuffrida, Hinckley, OH (US); Dustin A. Heldman, Shaker Heights, OH (US); and Thomas O. Mera, Columbus, OH (US)
Assigned to Great Lakes NeuroTechnologies Inc., Cleveland, OH (US)
Filed by Great Lakes NeuroTechnologies Inc., Cleveland, OH (US)
Filed on Aug. 25, 2020, as Appl. No. 17/001,777.
Application 17/001,777 is a continuation of application No. 15/847,970, filed on Dec. 20, 2017, granted, now 10,786,199.
Application 15/847,970 is a continuation of application No. 15/043,779, filed on Feb. 15, 2016, granted, now 9,877,680, issued on Jan. 30, 2018.
Application 15/043,779 is a continuation of application No. 14/192,990, filed on Feb. 28, 2014, granted, now 9,302,046, issued on Apr. 5, 2016.
Application 14/192,990 is a continuation of application No. 13/185,302, filed on Jul. 18, 2011, granted, now 8,702,629, issued on Apr. 22, 2014.
Application 13/185,302 is a continuation in part of application No. 11/082,668, filed on Mar. 17, 2005, granted, now 8,187,209, issued on May 29, 2012.
This patent is subject to a terminal disclaimer.
Int. Cl. A61B 5/00 (2006.01); A61B 5/11 (2006.01); A61B 5/389 (2021.01); A61M 5/172 (2006.01); A61N 1/36 (2006.01); A61N 1/372 (2006.01)
CPC A61B 5/4839 (2013.01) [A61B 5/0022 (2013.01); A61B 5/0024 (2013.01); A61B 5/1101 (2013.01); A61B 5/389 (2021.01); A61B 5/4082 (2013.01); A61B 5/6824 (2013.01); A61B 5/6826 (2013.01); A61M 5/1723 (2013.01); A61N 1/36067 (2013.01); A61N 1/36139 (2013.01); A61N 1/37282 (2013.01); A61B 5/1123 (2013.01); A61B 5/4836 (2013.01); A61B 5/7225 (2013.01); A61B 5/7264 (2013.01); A61B 5/7267 (2013.01); A61B 2562/0219 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A system for quantification and treatment of symptoms of a subject having a movement disorder, comprising:
a movement measuring device adapted for continuously or intermittently acquiring movement data corresponding to movement of a subject during activities of daily living and/or while performing at least one directed task, the movement measuring apparatus comprising at least one sensor having a signal from which the movement data is acquired,
at least one database comprising previous movement data from the subject and/or other subjects;
a processor comprising at least one algorithm, the processor in communication electrically or wirelessly with the movement measuring device and with the at least one database, the at least one algorithm adapted to quantify a severity of at least one symptom of the subject's movement disorder over a period of time and to calculate a new recommended treatment protocol based at least in part on the movement data and the previous movement data, the processor further being in wireless radio frequency communication for receiving the movement data and/or transmitting the new recommended treatment protocol; and
a treatment delivery device for receiving the new recommended treatment protocol calculated by the at least one algorithm and administering treatment, the treatment delivery device being programmable or reprogrammable based on a recommended treatment protocol.